p53 codon 72 polymorphism and its association with bladder cancer

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Background:

• The p53 codon 72 polymorphism (Arg/Pro) is studied for its role in various cancers.
• Previous research on p53 codon 72 and cancer risk, particularly bladder cancer, yielded controversial results.
• The Arg homozygosity at p53 codon 72 has been linked to increased cervical cancer risk.

Purpose of the Study:

• To investigate the association between the p53 codon 72 polymorphism and bladder cancer risk.
• To determine if p53 codon 72 Arg homozygosity is a risk factor for bladder cancer.
• To explore the potential role of human papilloma virus (HPV) in bladder cancer within this context.

Main Methods:

• A population-based case-control study design was employed.
• Peripheral blood samples were analyzed using allele-specific polymerase chain reaction (PCR) to genotype the p53 codon 72 polymorphism.
• Tumor specimens were tested for the presence of HPV.

Main Results:

• A statistically significant difference in p53 allele distribution was observed between bladder cancer patients and healthy controls (P<0.002).
• Homozygosity for arginine at p53 codon 72 (Arg/Arg genotype) was significantly associated with an increased risk of bladder cancer (Odds Ratio = 4.69, P<0.00002).
• Human papilloma virus (HPV) was detected in 12% of bladder cancer patients.

Conclusions:

• The p53 codon 72 polymorphism, specifically the Arg/Arg genotype, is implicated in bladder carcinogenesis.
• Individuals with the p53 Arg/Arg genotype face a significantly elevated risk of developing bladder cancer.
• This study provides novel evidence linking p53 codon 72 polymorphism to bladder cancer susceptibility.